Worthy Analytical Review for Sage Therapeutics, Inc. (NASDAQ:SAGE)


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Sage Therapeutics, Inc. (NASDAQ:SAGE) for the period of 9-Day stands at 73.93% while the stochastic %D for the same period stands at 57.79%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Sage Therapeutics, Inc. (NASDAQ:SAGE) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Buy”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for Sage Therapeutics, Inc. (NASDAQ:SAGE) while 20-100 Day MACD Oscillator indicates “Sell”.

Bollinger band is a volatility indicator of a certain security, currently Sage Therapeutics, Inc. (NASDAQ:SAGE)’s 20-Day Bollinger Band indicates “Buy”.

About Company

SAGE Therapeutics Inc. is a biopharmaceutical company developing and commercializing medicines to treat life-threatening central nervous system (CNS) disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Its initial product candidates include SAGE-547, SAGE-689 and SAGE-217. SAGE Therapeutics, Inc. is based in Cambridge, Massachusetts.

Previous Day Activity Analysis

On the last trading day, Sage Therapeutics, Inc. (NASDAQ:SAGE) opened the session at $96.7 and after going down -0.63% closed at $96.04. The stock lost -0.66 points in the last trade.

Sage Therapeutics, Inc. (NASDAQ:SAGE)’s stock fluctuated in the range of $92.20 and $98.80 during the previous active session. Sage Therapeutics, Inc. (NASDAQ:SAGE) traded with the volume of 1.75 Million with average volume of 661.24 Million. The stock has HIGH volatility on the last trading session.

Currently the Beta for the company remains at 2.75 while ATR (Average True Range) and RSI (Relative Strength Index) are at 5.34 and 80.14 respectively.

Currently the Insider Ownership of the shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) is at 0.9% and the shares outstanding are 37.78 Million.

Important Ratio Analysis

Some important ratios to consider here for Sage Therapeutics, Inc. (NASDAQ:SAGE) are discussed below:

Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The Price to Sale P/S and Price to Book P/B shows the value of 0 and 17.99 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 14.9 and 0 correspondingly.

The Quick Ratio of Sage Therapeutics, Inc. (NASDAQ:SAGE) stands at 5 while the Current Ratio depicts the value of 5.

Return on Assets ROA of Sage Therapeutics, Inc. (NASDAQ:SAGE) is at -78.9% whereas, Return on Equity ROE and Return of Investment ROI of Sage Therapeutics, Inc. (NASDAQ:SAGE) stand at -89.5% and 0% respectively.

Stock Performance Analysis

The stock performance of Sage Therapeutics, Inc. (NASDAQ:SAGE) on the basis of 5 day trade show the jump of 39.03% whereas, the monthly performance of the stock shows increase of 54.75%.

The quarterly performance of the stock remained in green zone with the value of 13.97% while six month performance of the shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) remained bullish with the count of 35.9%.

The yearly and YTD performance of Sage Therapeutics, Inc. (NASDAQ:SAGE) remained up at 86.96% and 88.09% respectively.